Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.45 and traded as low as $2.40. Evotec shares last traded at $2.41, with a volume of 168,413 shares trading hands.
Evotec Stock Down 3.6%
The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57. The stock’s 50 day simple moving average is $3.45 and its 200 day simple moving average is $3.45. The firm has a market cap of $795.83 million, a P/E ratio of 5.88 and a beta of 0.98.
About Evotec
Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.
The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.
Featured Stories
- Five stocks we like better than Evotec
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- Iran isn’t the real war
- This coin has everything going for it
- Only 500 people today…
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
